5 Recruiting Breast Neoplasms Clinical Trials in Arkansas
Explore active breast neoplasms research studies enrolling across Arkansas. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Breast Neoplasms Studies in Arkansas
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
📍 Research Site — Springdale, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
📍 Highlands Oncology Group - Duplicate 2 — Rogers, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
📍 St. Bernards Medical Center — Jonesboro, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
📍 Highlands Oncology Group — Springdale, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
📍 Local Institution - 0303 — Hot Springs, Arkansas
View Study & Checklist ➔